Clinical Trial Update: Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small-Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated adjuvant cisplatin with either genomic-guided vinorelbine or pemetrexed in early-stage non-small cell lung cancer. The study was termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Pemetrexed (pemetrexed)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Duke University | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: TERMINATED | Results posted: 2014-06-09